These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 328019)

  • 1. Pharmacokinetic studies with valproic acid in man.
    Klotz U
    Arzneimittelforschung; 1977; 27(5):1085-8. PubMed ID: 328019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations on valproic acid kinetics in patients with epilepsy.
    Johannessen SI
    Arzneimittelforschung; 1977; 27(5):1083-5. PubMed ID: 328018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients.
    Miljković B; Pokrajac M; Varagić V; Lević Z
    Int J Clin Pharmacol Res; 1991; 11(3):137-41. PubMed ID: 1809700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic elements of sodium valproate. Use in febrile convulsions in children].
    Perignon F; Novella-Pequinot MA; Beaune P; Lenoir G
    Arch Fr Pediatr; 1983 Jan; 40(1):47-50. PubMed ID: 6407454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of di-no-propylacetate and clonazepam in epileptic patients.
    Baruzzi A; Bordo B; Bossi L; Castelli D; Gerna M; Tognoni G; Zagnoni P
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):403-8. PubMed ID: 334679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of carbamazepine in the neonate and in the child.
    Rey E; d'Athis P; de Lauture D; Dulac O; Aicardi J; Olive G
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):90-6. PubMed ID: 422308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of valproic acid in man.
    Gugler R; Schell A; Eichelbaum M; Fröscher W; Schulz HU
    Eur J Clin Pharmacol; 1977 Oct; 12(2):125-32. PubMed ID: 336377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies of [14C]-flumecinol in humans.
    Klebovich I; Csetényi J; Kerpel-Fronius S; Vereczkey L
    Arzneimittelforschung; 1987 Mar; 37(3):368-71. PubMed ID: 3593454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of sodium valproate in epileptic patients.
    Perucca E; Gatti G; Frigo GM; Crema A; Calzetti S; Visintini D
    Br J Clin Pharmacol; 1978 Jun; 5(6):495-9. PubMed ID: 350251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic parameters of terbutaline in healthy man. An overview.
    Nyberg L
    Eur J Respir Dis Suppl; 1984; 134():149-60. PubMed ID: 6586475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the urinary excretion of metabolites of valproic acid (dipropylacetic acid) in rats and humans (author's transl)].
    Kochen W; Imbeck H; Jakobs C
    Arzneimittelforschung; 1977; 27(5):1090-9. PubMed ID: 328021
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of steady-state concentrations of valproic acid as determined from single plasma concentrations after the first dose.
    May CA; Garnett WR
    Clin Pharm; 1983; 2(2):143-7. PubMed ID: 6411412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
    Chen TL; Vogelsang GB; Petty BG; Brundrett RB; Noe DA; Santos GW; Colvin OM
    Drug Metab Dispos; 1989; 17(4):402-5. PubMed ID: 2571480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipropylacetate and hyperglycinemia.
    Similä S; von Wendt L; Linna SL; Saukkonen AL; Huhtaniemi I
    Neuropadiatrie; 1979 May; 10(2):158-60. PubMed ID: 386163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.